Tang Capital Management’s IRulya Therapeutics Inc. Common Stock IRLA Stock Holding History

Tang Capital Management’s Portfolio IRLA Stock Details IRLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-922	Closed	-$245K	–	214
2025 Q1	$245K	Buy	+922	New	+$282K	0.01%	194
2024 Q3	–	Sell	-7,500	Closed	-$1.13M	–	162
2024 Q2	$1.13M	Sell	7,500 -7,238	-49%	-$1.31M	0.11%	91
2024 Q1	$3.12M	Sell	14,738 -1,362	-8%	-$338K	0.33%	67
2023 Q4	$3.38M	Sell	16,100 -1,394	-8%	-$279K	0.31%	74
2023 Q3	$3.92M	Sell	17,494 -572	-3%	-$149K	0.55%	49
2023 Q2	$5.44M	Sell	18,066 -34	-0.2%	-$10.6K	0.8%	35
2023 Q1	$5.65M	Buy	+18,100	New	+$3.54M	0.84%	37

Other funds holding IRLA

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Rockefeller Capital Management New York $65.2B AUM 31.44% 1-Year Est. Return

Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

Tang Capital Management's IRLA Position: Q2 2025 in Review

Tang Capital Management sold out of IRulya Therapeutics Inc. Common Stock (IRLA) in Q2 2025, closing a stake of 922 shares — an estimated $245K sold.

Tang Capital Management first reported a position in IRLA in Q1 2023 and held it in 7 quarters. The position peaked at $5.65M in Q1 2023. 37 funds tracked by Wall St. Rank hold IRLA as of Q2 2025.

Tang Capital Management reported no remaining IRulya Therapeutics Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Tang Capital Management sold 922 IRulya Therapeutics Inc. Common Stock shares in Q2 2025, an estimated $245K.
Tang Capital Management first reported a position in IRulya Therapeutics Inc. Common Stock in Q1 2023 and held it in 7 quarters.
Tang Capital Management's IRulya Therapeutics Inc. Common Stock position peaked at $5.65M in Q1 2023.
37 funds tracked by Wall St. Rank held IRulya Therapeutics Inc. Common Stock as of Q2 2025.

Based on Tang Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.